Last reviewed · How we verify

Fresh frozen plasma

Rigshospitalet, Denmark · FDA-approved active Biologic

Fresh frozen plasma is a Blood product / Plasma derivative Biologic drug developed by Rigshospitalet, Denmark. It is currently FDA-approved for Coagulopathy with active bleeding or high bleeding risk, Massive transfusion / dilutional coagulopathy, Multiple clotting factor deficiency. Also known as: FFP, Blood Transfusion Centre Fresh Frozen Plasma, FFP, plasma, Blood products.

Fresh frozen plasma replaces deficient clotting factors and other plasma proteins to restore hemostatic function in patients with coagulopathy or massive bleeding.

Fresh frozen plasma replaces deficient clotting factors and other plasma proteins to restore hemostatic function in patients with coagulopathy or massive bleeding. Used for Coagulopathy with active bleeding or high bleeding risk, Massive transfusion / dilutional coagulopathy, Multiple clotting factor deficiency.

At a glance

Generic nameFresh frozen plasma
Also known asFFP, Blood Transfusion Centre Fresh Frozen Plasma, FFP, plasma, Blood products
SponsorRigshospitalet, Denmark
Drug classBlood product / Plasma derivative
ModalityBiologic
Therapeutic areaHematology / Transfusion Medicine
PhaseFDA-approved

Mechanism of action

Fresh frozen plasma (FFP) is a blood product containing all vitamin K-dependent clotting factors (II, V, VII, X), fibrinogen, and other plasma proteins. It is used to correct multiple factor deficiencies when specific factor replacement is unavailable or impractical, or in massive transfusion protocols to restore coagulation capacity and prevent dilutional coagulopathy.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Fresh frozen plasma

What is Fresh frozen plasma?

Fresh frozen plasma is a Blood product / Plasma derivative drug developed by Rigshospitalet, Denmark, indicated for Coagulopathy with active bleeding or high bleeding risk, Massive transfusion / dilutional coagulopathy, Multiple clotting factor deficiency.

How does Fresh frozen plasma work?

Fresh frozen plasma replaces deficient clotting factors and other plasma proteins to restore hemostatic function in patients with coagulopathy or massive bleeding.

What is Fresh frozen plasma used for?

Fresh frozen plasma is indicated for Coagulopathy with active bleeding or high bleeding risk, Massive transfusion / dilutional coagulopathy, Multiple clotting factor deficiency, Reversal of warfarin in emergency settings (when prothrombin complex concentrate unavailable), Thrombotic thrombocytopenic purpura (TTP) plasma exchange.

Who makes Fresh frozen plasma?

Fresh frozen plasma is developed and marketed by Rigshospitalet, Denmark (see full Rigshospitalet, Denmark pipeline at /company/rigshospitalet-denmark).

Is Fresh frozen plasma also known as anything else?

Fresh frozen plasma is also known as FFP, Blood Transfusion Centre Fresh Frozen Plasma, FFP, plasma, Blood products.

What drug class is Fresh frozen plasma in?

Fresh frozen plasma belongs to the Blood product / Plasma derivative class. See all Blood product / Plasma derivative drugs at /class/blood-product-plasma-derivative.

What development phase is Fresh frozen plasma in?

Fresh frozen plasma is FDA-approved (marketed).

What are the side effects of Fresh frozen plasma?

Common side effects of Fresh frozen plasma include Volume overload / fluid overload, Transfusion-related acute lung injury (TRALI), Allergic reaction, Transfusion-transmitted infection (rare with modern screening), Citrate toxicity (hypocalcemia).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing